Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,905,000 | 2,832,230 | -1,072,770 | $191.34M | $99.86M | 13.15% | -$91.48M |
| Liquidia Corporation(LQDA) | 2,435,000 | 2,545,000 | +110,000 | $84.98M | $88.82M | 11.70% | +$3.84M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,860,000 | 2,860,000 | 0 | $48.36M | $70.58M | 9.30% | +$22.22M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 453,739 | 500,000 | +46,261 | $19.12M | $39.61M | 5.22% | +$20.49M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 330,000 | 123,000 | -207,000 | $35.32M | $35.32M | 4.65% | $0 |
| Apogee Therapeutics Inc | 388,257 | 390,000 | +1,743 | $29.31M | $32.83M | 4.32% | +$3.52M |
| Disc Medicine, Inc.(IRON) | 200,000 | 421,000 | +221,000 | $15.88M | $26.92M | 3.55% | +$11.04M |
| UroGen Pharma Ltd.(URGN) | 268,423 | 1,430,000 | +1,161,577 | $6.29M | $25.71M | 3.39% | +$19.42M |
| Crescent Biopharma, Inc.(CBIO) | 1,178,300 | 1,312,615 | +134,315 | $13.97M | $24.11M | 3.18% | +$10.14M |
| Stoke Therapeutics, Inc.(STOK) | 695,000 | 700,000 | +5,000 | $22.06M | $22.79M | 3.00% | +$732.7K |
| Perspective Therapeutics, Inc.(CATX) | 1,184,500 | 4,675,000 | +3,490,500 | $4.99M | $19.49M | 2.57% | +$14.50M |
| Rezolute, Inc.(RZLT) | 6,287,156 | 6,300,000 | +12,844 | $14.84M | $19.21M | 2.53% | +$4.38M |
| MeiraGTx Holdings plc(MGTX) | 390,844 | 2,123,259 | +1,732,415 | $3.11M | $18.39M | 2.42% | +$15.28M |
| TG Therapeutics, Inc.(TGTX) | 535,000 | 535,000 | 0 | $15.95M | $17.77M | 2.34% | +$1.82M |
| SANUWAVE Health, Inc.(SNWV) | 981,267 | 981,267 | 0 | $29.28M | $16.97M | 2.23% | -$12.31M |
| Edgewise Therapeutics, Inc.(EWTX) | 500,000 | 500,000 | 0 | $12.41M | $15.75M | 2.07% | +$3.34M |
| Alpha Cognition Inc. Common Stock(ACOG) | 2,070,784 | 2,561,950 | +491,166 | $13.46M | $14.07M | 1.85% | +$605.0K |
| Annexon, Inc.(ANNX) | 2,600,000 | 2,331,761 | -268,239 | $13.05M | $12.92M | 1.70% | -$134.0K |
| Alumis Inc | 535,000 | 550,000 | +15,000 | $5.22M | $12.12M | 1.60% | +$6.89M |
| Codexis, Inc.(CDXS) | 6,789,738 | 6,785,000 | -4,738 | $11.07M | $11.06M | 1.46% | -$7.7K |
| Protagonist Therapeutics Inc | 105,000 | 100,000 | -5,000 | $9.17M | $10.54M | 1.39% | +$1.37M |
| Revolution Medicines, Inc.(RVMD) | 100,000 | 100,000 | 0 | $7.96M | $9.72M | 1.28% | +$1.76M |
| Xoma Royalty Corporation | 292,590 | 300,000 | +7,410 | $7.78M | $9.41M | 1.24% | +$1.63M |
| Q32 Bio Inc.(QTTB) | 213,363 | 1,256,228 | +1,042,865 | $708.4K | $8.06M | 1.06% | +$7.36M |
| MBX Biosciences, Inc.(MBX) | 260,000 | 260,000 | 0 | $8.20M | $7.76M | 1.02% | -$439.4K |
| Relmada Therapeutics, Inc.(RLMD) | 935,000 | 935,000 | 0 | $4.52M | $6.51M | 0.86% | +$1.99M |
| CG Oncology, Inc.(CGON) | 410,000 | 94,800 | -315,200 | $17.02M | $6.42M | 0.85% | -$10.61M |
| Jade Biosciences Inc | 427,608 | 427,608 | 0 | $6.60M | $6.01M | 0.79% | -$590.1K |
| Ocular Therapeutix, Inc.(OCUL) | 1,595,000 | 600,000 | -995,000 | $19.36M | $5.08M | 0.67% | -$14.28M |
| Assertio Holdings Inc | 0 | 265,707 | +265,707 | $0 | $5.06M | 0.67% | +$5.06M |
| Editas Medicine, Inc.(EDIT) | 0 | 1,926,997 | +1,926,997 | $0 | $4.76M | 0.63% | +$4.76M |
| Sutro Biopharma, Inc.(STRO) | 190,671 | 190,671 | 0 | $2.21M | $4.75M | 0.63% | +$2.54M |
| Journey Medical Corporation(DERM) | 975,000 | 960,000 | -15,000 | $7.52M | $4.50M | 0.59% | -$3.01M |
| Voyager Therapeutics, Inc.(VYGR) | 1,196,904 | 1,150,000 | -46,904 | $4.70M | $4.44M | 0.58% | -$264.8K |
| Trevi Therapeutics, Inc.(TRVI) | 345,100 | 345,100 | 0 | $4.32M | $4.12M | 0.54% | -$203.6K |
| Tectonic Therapeutic, Inc.(TECX) | 214,747 | 123,000 | -91,747 | $4.48M | $3.80M | 0.50% | -$677.7K |
| Cabaletta Bio, Inc.(CABA) | 900,000 | 1,380,000 | +480,000 | $1.97M | $3.71M | 0.49% | +$1.74M |
| Biodesix, Inc.(BDSX) | 0 | 238,047 | +238,047 | $0 | $3.45M | 0.45% | +$3.45M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 955,000 | 955,000 | 0 | $3.35M | $3.42M | 0.45% | +$66.8K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 1,400,906 | 1,412,656 | +11,750 | $1.89M | $3.31M | 0.44% | +$1.41M |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 245,000 | +245,000 | $0 | $3.14M | 0.41% | +$3.14M |
| Fortress Biotech, Inc.(FBIO) | 1,090,000 | 1,042,000 | -48,000 | $3.99M | $2.91M | 0.38% | -$1.08M |
| Opus Genetics, Inc.(IRD) | 1,120,000 | 1,120,000 | 0 | $2.25M | $2.25M | 0.30% | $0 |
| Rigel Pharmaceuticals, Inc.(RIGL) | 70,000 | 70,000 | 0 | $3.00M | $1.89M | 0.25% | -$1.11M |
| Atea Pharmaceuticals, Inc.(AVIR) | 179,815 | 322,600 | +142,785 | $641.9K | $1.74M | 0.23% | +$1.09M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 79,097 | +79,097 | $0 | $1.59M | 0.21% | +$1.59M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 75,000 | 125,000 | +50,000 | $1.18M | $1.58M | 0.21% | +$396.0K |
| Nextcure Inc | 0 | 141,181 | +141,181 | $0 | $1.51M | 0.20% | +$1.51M |
| 4d Molecular Therapeutics In | 0 | 112,291 | +112,291 | $0 | $1.05M | 0.14% | +$1.05M |
| Perspective Therapeutics, Inc.CALL(CATX) | 0 | 200,000 | +200,000 | $0 | $834.0K | 0.11% | +$834.0K |
| Protalix BioTherapeutics, Inc.(PLX) | 2,478,176 | 340,000 | -2,138,176 | $4.46M | $737.8K | 0.10% | -$3.72M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 53,282 | +53,282 | $0 | $476.9K | 0.06% | +$476.9K |
| LB Pharmaceuticals Inc(LBRX) | 0 | 14,506 | +14,506 | $0 | $357.7K | 0.05% | +$357.7K |
| Adagio Medical Holdings, Inc.(ADGM) | 18,444 | 18,444 | 0 | $19.2K | $21.2K | 0.00% | +$2.0K |
| Alkermes plcSHS(ALKS) | 490,000 | 0 | -490,000 | $13.71M | $0 | — | -$13.71M |
| Assertio Holdings Inc | 285,000 | 0 | -285,000 | $2.58M | $0 | — | -$2.58M |
| BridgeBio Pharma, Inc.(BBIO) | 18,319 | 0 | -18,319 | $1.40M | $0 | — | -$1.40M |
| Generation Bio Co | 310,000 | 0 | -310,000 | $1.76M | $0 | — | -$1.76M |
| Gossamer Bio, Inc.(GOSS) | 2,720,000 | 0 | -2,720,000 | $8.43M | $0 | — | -$8.43M |
| Karyopharm Therapeutics Inc.(KPTI) | 930,000 | 0 | -930,000 | $6.84M | $0 | — | -$6.84M |
| Rapt Therapeutics Inc | 150,000 | 0 | -150,000 | $213.4K | $0 | — | -$213.4K |
| Silence Therapeutics plcADS(SLN) | 78,926 | 0 | -78,926 | $479.9K | $0 | — | -$479.9K |
| Ventyx Biosciences Inc | 251,932 | 0 | -251,932 | $2.27M | $0 | — | -$2.27M |
| Zymeworks Inc.(ZYME) | 108,929 | 0 | -108,929 | $2.87M | $0 | — | -$2.87M |